TAOPING INC (TAOP)

VGG8675V1278 - Common Stock

0.3986  0 (-0.97%)

After market: 0.3901 -0.01 (-2.13%)

Fundamental Rating

2

Taking everything into account, TAOP scores 2 out of 10 in our fundamental rating. TAOP was compared to 85 industry peers in the IT Services industry. Both the profitability and financial health of TAOP have multiple concerns. TAOP is valied quite expensively at the moment, while it does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year TAOP was profitable.
TAOP had a negative operating cash flow in the past year.
TAOP had negative earnings in each of the past 5 years.
TAOP had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a decent Return On Assets value of 4.99%, TAOP is doing good in the industry, outperforming 65.06% of the companies in the same industry.
The Return On Equity of TAOP (10.73%) is better than 68.67% of its industry peers.
With a decent Return On Invested Capital value of 4.43%, TAOP is doing good in the industry, outperforming 61.45% of the companies in the same industry.
Industry RankSector Rank
ROA 4.99%
ROE 10.73%
ROIC 4.43%
ROA(3y)-15.81%
ROA(5y)-22.75%
ROE(3y)-43.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 3.99%, TAOP is in line with its industry, outperforming 56.63% of the companies in the same industry.
TAOP has a Operating Margin (3.18%) which is comparable to the rest of the industry.
Looking at the Gross Margin, with a value of 21.39%, TAOP is doing worse than 78.31% of the companies in the same industry.
TAOP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.18%
PM (TTM) 3.99%
GM 21.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.28%
GM growth 5Y-13.42%

2

2. Health

2.1 Basic Checks

TAOP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for TAOP has been increased compared to 1 year ago.
The number of shares outstanding for TAOP has been increased compared to 5 years ago.
TAOP has a worse debt/assets ratio than last year.

2.2 Solvency

TAOP has an Altman-Z score of -6.34. This is a bad value and indicates that TAOP is not financially healthy and even has some risk of bankruptcy.
TAOP has a worse Altman-Z score (-6.34) than 95.18% of its industry peers.
A Debt/Equity ratio of 0.52 indicates that TAOP is somewhat dependend on debt financing.
TAOP has a Debt to Equity ratio (0.52) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z -6.34
ROIC/WACC0.6
WACC7.34%

2.3 Liquidity

A Current Ratio of 1.50 indicates that TAOP should not have too much problems paying its short term obligations.
TAOP's Current ratio of 1.50 is in line compared to the rest of the industry. TAOP outperforms 46.99% of its industry peers.
TAOP has a Quick Ratio of 1.33. This is a normal value and indicates that TAOP is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.33, TAOP is in line with its industry, outperforming 40.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.33

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 114.29% over the past year.
The Revenue has grown by 37.49% in the past year. This is a very strong growth!
Measured over the past years, TAOP shows a quite strong growth in Revenue. The Revenue has been growing by 13.40% on average per year.
EPS 1Y (TTM)114.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.8%
Revenue 1Y (TTM)37.49%
Revenue growth 3Y51.55%
Revenue growth 5Y13.4%
Sales Q2Q%28.42%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.63 indicates a rather cheap valuation of TAOP.
Based on the Price/Earnings ratio, TAOP is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 29.12, TAOP is valued rather cheaply.
Industry RankSector Rank
PE 0.63
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TAOP indicates a rather cheap valuation: TAOP is cheaper than 97.59% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.54

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

TAOP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TAOPING INC

NASDAQ:TAOP (11/12/2024, 8:00:01 PM)

After market: 0.3901 -0.01 (-2.13%)

0.3986

0 (-0.97%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.64M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 0.63
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.99%
ROE 10.73%
ROCE
ROIC
ROICexc
ROICexgc
OM 3.18%
PM (TTM) 3.99%
GM 21.39%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.5
Quick Ratio 1.33
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)114.29%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)37.49%
Revenue growth 3Y51.55%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y